SAME is different: A case report and literature review of staphylococcus aureus metastatic endophthalmitis

Southern Medical Journal

Volumn 102, Issue 9, 2009, Pages 952-956

  Tang, Johnny ^a   Nixdorff, Neil A ^b   Mourad, Ronda ^b   Skalweit, Marion J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NONE

Author keywords

Bacteremia; Diabetes; Metastatic endophthalmitis; Staphylococcus aureus

Indexed keywords

CEFAZOLIN; CEFEPIME; CEFTAZIDIME; DEXAMETHASONE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CASE REPORT; CELLULITIS; CLINICAL FEATURE; DRUG SUBSTITUTION; ENDOPHTHALMITIS; HUMAN; MALE; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS; VISUAL ACUITY;

AGED; BACTEREMIA; DIABETIC FOOT; ENDOPHTHALMITIS; HUMANS; MALE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 70349092743     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181b21a40     Document Type: Article

References (14)

1. Keswani T, Ahuja V, Changulani M. Evaluation of outcome of various treatment methods for endogenous endophthalmitis. Indian J Med Sci 2006;60:454-460.
2. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endoph-thalmitis. Report of a ten-year retrospective study. Ophthalmology 1994; 101:832-838.
3. Wong JS, Chan TK, Lee HM, et al. Endogenous bacterial endophthalmi-tis: an east asian experience and a reappraisal of a severe ocular affliction. Ophthalmology 2000;107:1483-1491.
4. Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial en-dophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003;48:403-423.
5. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol 1986;31:81-101.
6. Callegan MC, Booth MC, Jett BD, et al. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun 1999;67:3348-3356.
7. Agrawal P, Yellachich D, Kirkpatrick N. Retinal detachment following meningococcal endophthalmitis. Eye 2007;21:450-451.
8. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995;113:1479-1496.
9. De Kaspar HM, Ta CN, Engelbert M, et al. Effects of intravitreal cor-ticosteroid in the treatment of Staphylococcus aureus-induced experiment endophthalmitis. Retina 2008;28:326-332.
10. Yoshizumi MO, Lee GC, Equi RA, et al. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis. Retina 1998;18:130-135.
11. Benz MS, Scott IU, Flynn HW Jr, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004;137:38-42.
12. Okhravi N, Towler HM, Hykin P, et al. Assessment of a standard treatment protocol on visual outcome following presumed bacterial endoph-thalmitis. Br J Ophthalmol 1997;81:719-725.
13. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272.
14. Blyth CC, Darragh H, Whelan A, et al. Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia. Intern Med J 2002;32:224-232.